Lung Cancer Associated With Cystic Airspaces

2

Review clinical trials related to Lung Cancer Associated With Cystic Airspaces. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces

The goal of this observational study is to determine the most accurate tumor size measurement method for T-staging and prognostic assessment in lung cancer with cystic airspaces (LCCA). The main questions it aims to answer are: * What is the optimal T-staging approach for accurately classifying lung cancer with cystic airspaces (LCCA) and predicting patient outcomes? * How do imaging features of cystic lesions correlate with their pathological characteristics? * What is the relationship between imaging features of cystic airspace-associated lesions and patient prognosis? * Can optimizing the T-staging method improve clinical decision-making in patients with LCCA?

Participants needed: 500
Trial details
Biological sex: AllType: ObservationalSponsor: Central South UniversityUpdated: Mar 18, 2026Locations: 1
Eligibility criteria

Histologically confirmed non-small cell lung cancer (NSCLC), as verified by biop... [+3]

History of pulmonary diseases that could produce cystic lung lesions (e.g., tube... [+3]

Status: Recruiting

Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes

The goal of this observational study is to investigate the multi-omics characterization early-stage lung cancer exhibiting distinct phenotypes including lung cancer associated with cystic airspaces, multiple primary lung cancers, and so on. The main questions it aims to answer are: * What are the differences in pathogenesis of non-small cell lung cancer with different phenotypes explored by multi-omics? * Whether differential genes lead to potential prognostic models and therapeutic targets? Participants will be followed up after surgery to answer prognosis: whether they have recurred, and the time to recurrence.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Central South UniversityUpdated: Mar 18, 2026Locations: 1
Eligibility criteria

Male or female patients:18-75 years old; [+5]

A history of previous or co-existing malignant tumors; [+9]